People · Operator
Named in public records as an officer, director or promoter · active 2026–2026 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Accretion Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $750K | $1.3M | 2026 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.